Colinz Laboratories P/E Ratio
Current P/E Ratio
6.62
Low Valuation
Very Low - Potentially undervalued or facing challenges
Colinz Laboratories P/E ratio. Colinz Laboratories (COLINZ) P/E ratio is 6.62 (Low), EPS (TTM) ₹2.04, current price ₹73.00 on BSE — Very Low - Potentially undervalued or facing challenges. Check COLINZ market capitalization to track the company's total market size over time.
Current Valuation Metrics
P/E Ratio
6.62
Current Price
₹73.00
EPS (TTM)
₹2.04
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
56.47
Sector Median
32.41
Sector Rank
#10 of 199
Sector Percentile
5.0%
COLINZ P/E Ratio — Valuation Signal & Historical Context
Colinz Laboratories P/E 6.62 — signal: Undervalued. Also explore COLINZ share price history to track price trends across different timeframes.
- Stock appears undervalued with PE of 6.62, suggesting potential buying opportunity
- Trading at discount to sector average PE of 56.47
COLINZ vs Healthcare Peers — P/E Ratio Comparison
Colinz Laboratories P/E 6.62 vs Healthcare average 56.47, median 32.41 — range 2.04–740.29.
Sector Average
56.47
Sector Median
32.41
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Shelter Pharma | SHELTER | 6.96 | ₹59 | Low |